Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075).
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D002499:Centrifugation, Density Gradient; D002850:Chromatography, Gel; D002855:Chromatography, Thin Layer; D004254:DNA Nucleotidyltransferases / Q000032:analysis; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D012321:DNA-Directed RNA Polymerases / Q000032:analysis; D007939:Leukemia L1210 / Q000378:metabolism*; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D010946:Plants, Medicinal; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D013056:Spectrophotometry, Ultraviolet; D013936:Thymidine / Q000378:metabolism; D013942:Thymine Nucleotides / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014500:Uracil Nucleotides / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D000470:Alkaloids; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D013942:Thymine Nucleotides; D014500:Uracil Nucleotides; D014316:Tritium; D004254:DNA Nucleotidyltransferases; D012321:DNA-Directed RNA Polymerases; D013936:Thymidine; D014529:Uridine